Clinical Trials Browser

Phase 3 × Not yet recruiting × Lymphoma, Large B-Cell, Diffuse × Clear all

NCT07409428 2026-02-13

A Phase III Study of HMPL-760 in Combination With R-GemOx Versus Placebo in Combination With R-GemOx in Relapsed/Refractory DLBCL

Phase 3 Not yet recruiting

Lymphoma, Large B-Cell, Diffuse

NCT06573645 2024-08-27

A Phase III Clinical Trial of High-dose Rituximab (500mg/m²) Combined With CHOP Regimen in the Treatment of Male Patient With Newly Diagnosed Advanced DLBCL

Phase 3 Not yet recruiting

Lymphoma, Lymphoma, Large B-Cell, Diffuse